Summit Therapeutics PLC (SMMT) — Free Cash Flow Generation Index
Summit Therapeutics PLC (SMMT) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of $4.24 Million represents 1% of operating cash flow ($4.23 Million). See SMMT current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Summit Therapeutics PLC Free Cash Flow Generation Index (2004–2016)
Historical FCF Generation Index trend for Summit Therapeutics PLC across 2 annual periods. Explore Summit Therapeutics PLC debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Summit Therapeutics PLC (2004–2016)
Year-by-year Free Cash Flow Generation Index for Summit Therapeutics PLC. For the full company profile including market capitalisation, see SMMT market cap.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.99x | $15.07 Million | $15.18 Million | $110.00K | ▲ +29.5% |
| 2004 | 0.77x | $43.30K | $56.48K | $13.18K | — |